Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 598
Selected: 0
NCT IDTitle
NCT00003414Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease
NCT06610682A Trial to Evaluate CSF ctDNA and Safety of Plixorafenib Alone or With Retifanlimab in Patients With BRAF-altered Glioma
NCT06027086DRP-104 (Glutamine Antagonist) in Combination With Durvalumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)
NCT05103722Combined Aerobic and Resistance Exercise Training in Metastatic Renal Cell Carcinoma
NCT01666353PET Quantitative Assessments of Solid Tumor Response to Immune Checkpoint Blockade Therapy
NCT01763931DIG-HIF-1 Pharmacodynamic Trial in Newly Diagnosed Operable Breast Cancer
NCT07836101Study of Sarilumab With Immune Checkpoint Inhibitor Rechallenge in Patients With Clinically Significant Immune Related Adverse Events
NCT00897611Tumor DNA and MRI/CT Scan Findings in Patients With Grade III or Grade IV Malignant Glioma
NCT00343447Cyclophosphamide and Rituximab Followed By Vaccine Therapy in Treating Patients With Chronic Lymphocytic Leukemia
NCT02716974A Study of Definitive Therapy to Treat Prostate Cancer
NCT00003960Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
NCT02215876Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Eribulin Chemotherapy (ACE) in Operable HER2-negative Breast Cancer
NCT03044613Nivolumab +/- Relatlimab Prior to Chemoradiation With II/III Gastro/Esophageal Cancer
NCT01836068Optimized Antiretroviral Therapy During Allogeneic Hematopoietic Stem Cell Transplantation in HIV-1 Individuals
NCT01607008MRI for Assessing Prostate Cancer Response
NCT07439172Pre-Radiation Chemotherapy for Newly Diagnosed High-Grade Glioma.
NCT02575794Terameprocol in Treating Patients With Recurrent High Grade Glioma
NCT00005639Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment
NCT06210854Assessing Administration of pBI-11 Via Electroporation for the Treatment of Patients With HPV16/18+
NCT02981524Study of GVAX (With CY) and Pembrolizumab in MMR-p Advanced Colorectal Cancer
NCT01845805Trial to Improve Outcomes in Patients With Resected Pancreatic Cancer (Azacitidine)
NCT03299946Feasibility and Efficacy of Neoadjuvant Cabozantinib Plus Nivolumab (CaboNivo) Followed by Definitive Resection for Patients With Locally Advanced Hepatocellular Carcinoma (HCC)
NCT01665768Maintenance Rituximab With mTor Inhibition After High-dose Consolidative Therapy in Lymphoma
NCT06361810PSMA Therapy and Immunotherapy in Kidney Cancer
NCT05254184KRAS-Targeted Vaccine With Chemoimmunotherapy, Nivolumab and Ipilimumab for Patients With NSCLC
NCT00465907Study of Weekly Paclitaxel, Carboplatin and Irinotecan to Treat Lung Cancer
NCT00022399Celecoxib Compared With No Treatment Before Surgery in Treating Patients With Localized Prostate Cancer
NCT03909464Non-Invasive Neurosensory Testing For Chemotherapy-Induced Peripheral Neuropathy
NCT00478062Vaccine Therapy in Treating Patients Who Have Received First-Line Therapy for Hodgkin's Lymphoma
NCT02370836Evaluating the Effects of Psycho-oncological Education on Distress and Quality of Life in Solid Tumor Cancer Patients
NCT07430202A DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Glutamine Antagonist DRP-104, Nivolumab, and Ipilimumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)
NCT03250299Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
NCT04376229Proton Radiation Therapy Registry
NCT01700673Phase II Study of Azacitidine and Sargramostim as Maintenance Treatment for Poor-Risk AML or MDS
NCT017514513-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy
NCT01282216Patient-donor Vaccination in the Context of Allogeneic Bone Marrow Transplant With Post-transplant Cyclophosphamide
NCT02601014Biomarker-Driven Therapy With Nivolumab and Ipilimumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Expressing AR-V7
NCT03246074Clinical Trial of Combined Fostamatinib and Paclitaxel in Ovarian Cancer
NCT02115828A Study of Vismodegib in Men With Metastatic CRPC With Accessible Metastatic Lesions for Tumor Biopsy
NCT00005859Tipifarnib in Treating Patients With Recurrent or Progressive Malignant Glioma
NCT06922318The COSMYC Trial (COmbined Suppression of MYC)
NCT02512172A Study of Enhancing Response to MK-3475 in Advanced Colorectal Cancer
NCT01591954A Feasibility Study of a Modular Video Augmentation System for Image-Guided Skull Base Surgery
NCT01493154Safety Study of HPV DNA Vaccine to Treat Head and Neck Cancer Patients
NCT00003962Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
NCT03507608Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Suppression
NCT07793240Circulating Tumor DNA (ctDNA) in High Grade Upper Tract Urothelial Cancer (UTUC)
NCT03576274Combined Technology Enhanced Home Exercise Program and Other Non-pharmacological Intervention for Cancer Survivors
NCT06059118Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
NCT01934855Tumor Motion Management in Radiotherapy Using 4D-MRI